• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白对小胶质细胞的预处理强烈影响 Toll 样受体(TLR)刺激诱导的反应。

Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.

机构信息

CABIMER, Andalusian Center for Molecular Biology and Regenerative Medicine, Seville, Spain.

出版信息

PLoS One. 2013 Nov 13;8(11):e79160. doi: 10.1371/journal.pone.0079160. eCollection 2013.

DOI:10.1371/journal.pone.0079160
PMID:24236103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3827304/
Abstract

In recent years, it has become accepted that α-synuclein (αSyn) has a key role in the microglia-mediated neuroinflammation, which accompanies the development of Parkinson's disease and other related disorders, such as Dementia with Lewy Bodies and Alzheimer's disease. Nevertheless, the cellular and molecular mechanisms underlying its pathological actions, especially in the sporadic forms of the diseases, are not completely understood. Intriguingly, several epidemiological and animal model studies have revealed a link between certain microbial infections and the onset or progression of sporadic forms of these neurodegenerative disorders. In this work, we have characterized the effect of toll-like receptor (TLR) stimulation on primary murine microglial cultures and analysed the impact of priming cells with extracellular wild-type (Wt) αSyn on the subsequent TLR stimulation of cells with a set of TLR ligands. By assaying key interleukins and chemokines we report that specific stimuli, in particular Pam3Csk4 (Pam3) and single-stranded RNA40 (ssRNA), can differentially affect the TLR2/1- and TLR7-mediated responses of microglia when pre-conditioned with αSyn by augmenting IL-6, MCP-1/CCL2 or IP-10/CXCL10 secretion levels. Furthermore, we report a skewing of αSyn-primed microglia stimulated with ssRNA (TLR7) or Pam3 (TLR2/1) towards intermediate but at the same time differential, M1/M2 phenotypes. Finally, we show that the levels and intracellular location of activated caspase-3 protein change significantly in αSyn-primed microglia after stimulation with these particular TLR agonists. Overall, we report a remarkable impact of non-aggregated αSyn pre-sensitization of microglia on TLR-mediated immunity, a phenomenon that could contribute to triggering the onset of sporadic α-synuclein-related neuropathologies.

摘要

近年来,人们已经接受了α-突触核蛋白(αSyn)在小胶质细胞介导的神经炎症中的关键作用,这种炎症伴随着帕金森病和其他相关疾病的发展,如路易体痴呆和阿尔茨海默病。然而,其病理作用的细胞和分子机制,特别是在疾病的散发性形式中,还不完全清楚。有趣的是,几项流行病学和动物模型研究表明,某些微生物感染与这些神经退行性疾病的散发性形式的发病或进展之间存在联系。在这项工作中,我们描述了 Toll 样受体(TLR)刺激对原代小鼠小胶质细胞培养物的影响,并分析了用细胞外野生型(Wt)αSyn 预刺激细胞对随后用一组 TLR 配体刺激细胞的影响。通过检测关键的白细胞介素和趋化因子,我们报告说,特定的刺激物,特别是 Pam3Csk4(Pam3)和单链 RNA40(ssRNA),在通过增加 IL-6、MCP-1/CCL2 或 IP-10/CXCL10 分泌水平用 αSyn 预条件化后,可以有差异地影响 TLR2/1 和 TLR7 介导的小胶质细胞反应。此外,我们报告说,用 ssRNA(TLR7)或 Pam3(TLR2/1)刺激的αSyn 预刺激小胶质细胞向中间但同时又不同的 M1/M2 表型倾斜。最后,我们发现在用这些特定的 TLR 激动剂刺激后,αSyn 预刺激的小胶质细胞中激活的 caspase-3 蛋白的水平和细胞内位置发生了显著变化。总的来说,我们报告了非聚集的αSyn 预致敏小胶质细胞对 TLR 介导的免疫的显著影响,这种现象可能有助于触发散发性α-突触核蛋白相关神经病理学的发病。

相似文献

1
Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.α-突触核蛋白对小胶质细胞的预处理强烈影响 Toll 样受体(TLR)刺激诱导的反应。
PLoS One. 2013 Nov 13;8(11):e79160. doi: 10.1371/journal.pone.0079160. eCollection 2013.
2
Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.在离体小胶质细胞培养物和使用小胶质细胞减少的小鼠体内模型中,Toll 样受体激动剂刺激后的先天免疫反应。
J Neuroinflammation. 2021 Sep 6;18(1):194. doi: 10.1186/s12974-021-02240-w.
3
The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration.单个及成对Toll样受体激活对神经炎症和神经退行性变的影响。
J Neuroinflammation. 2014 Sep 20;11:166. doi: 10.1186/s12974-014-0166-7.
4
Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.非聚集态 α-突触核蛋白在小鼠中引发的神经胶质固有免疫:野生型与帕金森病相关突变体之间的差异。
PLoS One. 2010 Oct 26;5(10):e13481. doi: 10.1371/journal.pone.0013481.
5
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.可溶性 α-突触核蛋白抗体复合物激活人诱导多能干细胞源性小胶质细胞中的 NLRP3 炎性体。
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025847118.
6
Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.系统性红斑狼疮患者外周血淋巴细胞 Toll 样受体的激活谱。
Clin Exp Immunol. 2010 Jan;159(1):11-22. doi: 10.1111/j.1365-2249.2009.04036.x. Epub 2009 Oct 16.
7
Retinal pigment epithelium cells alter the pro-inflammatory response of retinal microglia to TLR-3 stimulation.视网膜色素上皮细胞改变视网膜小胶质细胞对TLR-3刺激的促炎反应。
Acta Ophthalmol. 2014 Dec;92(8):e621-9. doi: 10.1111/aos.12472. Epub 2014 Jun 15.
8
The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.TLR7/TLR8 和 TLR9 配体可恢复皮肤扁平苔藓中由 Toll 样受体激活引发的功能失调的固有免疫反应。
Br J Dermatol. 2015 Jan;172(1):48-55. doi: 10.1111/bjd.13214. Epub 2014 Nov 20.
9
Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.Toll 样受体 3(一种抗病毒信号分子)及其相关基因在阿尔茨海默病脑中的表达增加。
Exp Neurol. 2018 Nov;309:91-106. doi: 10.1016/j.expneurol.2018.07.016. Epub 2018 Aug 1.
10
Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.坏死神经元通过MyD88依赖途径诱导谷氨酰胺酶,增强小胶质细胞的神经毒性。
J Neuroinflammation. 2008 Oct 9;5:43. doi: 10.1186/1742-2094-5-43.

引用本文的文献

1
Fortilin binds CTNNA3 and protects it against phosphorylation, ubiquitination, and proteasomal degradation to guard cells against apoptosis.福替林与α - 连环蛋白3结合,保护其免受磷酸化、泛素化和蛋白酶体降解,从而保护细胞免受凋亡。
Commun Biol. 2025 Jan 2;8(1):1. doi: 10.1038/s42003-024-07399-5.
2
Aged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the Connection.小胶质细胞的衰老相关变化与神经退行性疾病:探索两者之间的联系
Biomedicines. 2024 Aug 2;12(8):1737. doi: 10.3390/biomedicines12081737.
3
The immune system in Parkinson's disease: what we know so far.

本文引用的文献

1
α-Synuclein oligomers and clinical implications for Parkinson disease.α-突触核蛋白寡聚物与帕金森病的临床意义。
Ann Neurol. 2013 Feb;73(2):155-69. doi: 10.1002/ana.23746. Epub 2012 Dec 7.
2
Cutting edge: IL-13Rα1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide.前沿:白细胞介素-13 受体 α1 在多巴胺能神经元中的表达有助于其在慢性外周脂多糖处理后发生氧化应激介导的损失。
J Immunol. 2012 Dec 15;189(12):5498-502. doi: 10.4049/jimmunol.1102150. Epub 2012 Nov 19.
3
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
帕金森病中的免疫系统:目前我们所知的。
Brain. 2024 Oct 3;147(10):3306-3324. doi: 10.1093/brain/awae177.
4
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson's Disease.考替司他丁:一种治疗帕金森病的新型多模态治疗方法。
Int J Mol Sci. 2024 Jan 5;25(2):694. doi: 10.3390/ijms25020694.
5
Clinical biomarkers for Lewy body diseases.路易体疾病的临床生物标志物
Cell Biosci. 2023 Nov 14;13(1):209. doi: 10.1186/s13578-023-01152-x.
6
Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson's disease.尼可刹米通过抑制坏死性凋亡、神经炎症和α-突触核蛋白寡聚体化,发挥神经保护作用,在亚急性 MPTP 帕金森病小鼠模型中。
Sci Rep. 2023 May 31;13(1):8783. doi: 10.1038/s41598-023-35975-y.
7
The role of microglia in 67NR mammary tumor-induced suppression of brain responses to immune challenges in female mice.小胶质细胞在67NR乳腺肿瘤诱导雌性小鼠大脑对免疫刺激反应抑制中的作用。
J Neurochem. 2024 Oct;168(10):3482-3499. doi: 10.1111/jnc.15830. Epub 2023 May 10.
8
Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.胶质母细胞瘤相关的小胶质细胞/巨噬细胞(GAMs):肿瘤微环境中的免疫功能及其对免疫治疗的影响。
Front Immunol. 2023 Mar 9;14:1123853. doi: 10.3389/fimmu.2023.1123853. eCollection 2023.
9
A functional role for alpha-synuclein in neuroimmune responses.α-突触核蛋白在神经免疫反应中的功能作用。
J Neuroimmunol. 2023 Mar 15;376:578047. doi: 10.1016/j.jneuroim.2023.578047. Epub 2023 Feb 8.
10
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders.基于纳米医学的治疗策略在中枢神经系统疾病治疗中的作用。
Molecules. 2023 Jan 28;28(3):1283. doi: 10.3390/molecules28031283.
病理性α-突触核蛋白的传递会在非转基因小鼠中引发类似帕金森病的神经退行性变。
Science. 2012 Nov 16;338(6109):949-53. doi: 10.1126/science.1227157.
4
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.帕金森病患者的总脑脊液 α-突触核蛋白含量低于健康受试者。
Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004. Epub 2012 Nov 10.
5
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'.利用单核细胞衍生的巨噬细胞控制中枢神经系统疾病:不再是“是否”,而是“如何”。
J Pathol. 2013 Jan;229(2):332-46. doi: 10.1002/path.4106. Epub 2012 Nov 28.
6
A rationally designed six-residue swap generates comparability in the aggregation behavior of α-synuclein and β-synuclein.合理设计的六残基替换可产生α-突触核蛋白和β-突触核蛋白聚集行为的可比性。
Biochemistry. 2012 Nov 6;51(44):8771-8. doi: 10.1021/bi300558q. Epub 2012 Oct 22.
7
The role of glia in α-synucleinopathies.胶质细胞在α-突触核蛋白病中的作用。
Mol Neurobiol. 2013 Apr;47(2):575-86. doi: 10.1007/s12035-012-8340-3. Epub 2012 Sep 2.
8
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.脂多糖诱导的小胶质细胞激活和对实验性脑损伤的神经保护作用与血源性 TLR4 无关。
J Neurosci. 2012 Aug 22;32(34):11706-15. doi: 10.1523/JNEUROSCI.0730-12.2012.
9
Alpha-synuclein: from secretion to dysfunction and death.α-突触核蛋白:从分泌到功能障碍和死亡。
Cell Death Dis. 2012 Jul 19;3(7):e350. doi: 10.1038/cddis.2012.94.
10
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.在过表达人野生型α-突触核蛋白的年轻小鼠中,区域特异性小胶质细胞激活。
Exp Neurol. 2012 Oct;237(2):318-34. doi: 10.1016/j.expneurol.2012.06.025. Epub 2012 Jun 27.